The present invention is directed towards the treatment of spinal disorders and pain. More particularly, the present invention is directed to systems and methods of treating the spine, which eliminate pain and enable spinal motion, which effectively mimics that of a normally functioning spine.
The superior vertebra with its inferior facets, the inferior vertebra with its superior facet joints, the intervertebral disc, and seven spinal ligaments (not shown) extending between the superior and inferior vertebrae together comprise a spinal motion segment or functional spine unit. Each spinal motion segment enables motion along three orthogonal axes, both in rotation and in translation. The various spinal motions are illustrated in
Traumatic, inflammatory, metabolic, synovial, neoplastic and degenerative disorders of the spine can produce debilitating pain that can affect a spinal motion segment's ability to properly function. The specific location or source of spinal pain is most often an affected intervertebral disc or facet joint. Often, a disorder in one location or spinal component can lead to eventual deterioration or disorder, and ultimately, pain in the other.
Spine fusion (arthrodesis) is a procedure in which two or more adjacent vertebral bodies are fused together. It is one of the most common approaches to alleviating various types of spinal pain, particularly pain associated with one or more affected intervertebral discs. While spine fusion generally helps to eliminate certain types of pain, it has been shown to decrease function by limiting the range of motion for patients in flexion, extension, rotation and lateral bending. Furthermore, the fusion creates increased stresses on adjacent non-fused motion segments and accelerated degeneration of the motion segments. Additionally, pseudarthrosis (resulting from an incomplete or ineffective fusion) may not provide the expected pain-relief for the patient. Also, the device(s) used for fusion, whether artificial or biological, may migrate out of the fusion site creating significant new problems for the patient.
Various technologies and approaches have been developed to treat spinal pain without fusion in order to maintain or recreate the natural biomechanics of the spine. To this end, significant efforts are being made in the use of implantable artificial intervertebral discs. Artificial discs are intended to restore articulation between vertebral bodies so as to recreate the full range of motion normally allowed by the elastic properties of the natural disc. Unfortunately, the currently available artificial discs do not adequately address all of the mechanics of motion for the spinal column.
It has been found that the facet joints can also be a significant source of spinal disorders and debilitating pain. For example, a patient may suffer from arthritic facet joints, severe facet joint tropism, otherwise deformed facet joints, facet joint injuries, etc. These disorders lead to spinal stenosis, degenerative spondylolithesis, and/or isthmic spondylotlisthesis, pinching the nerves that extend between the affected vertebrae.
Current interventions for the treatment of facet joint disorders have not been found to provide completely successful results. Facetectomy (removal of the facet joints) may provide some pain relief; but as the facet joints help to support axial, torsional, and shear loads that act on the spinal column in addition to providing a sliding articulation and mechanism for load transmission, their removal inhibits natural spinal function. Laminectomy (removal of the lamina, including the spinal arch and the spinous process) may also provide pain relief associated with facet joint disorders; however, the spine is made less stable and subject to hypermobility. Problems with the facet joints can also complicate treatments associated with other portions of the spine. In fact, contraindications for disc replacement include arthritic facet joints, absent facet joints, severe facet joint tropism, or otherwise deformed facet joints due to the inability of the artificial disc (when used with compromised or missing facet joints) to properly restore the natural biomechanics of the spinal motion segment.
While various attempts have been made at facet joint replacement, they have been inadequate. This is due to the fact that prosthetic facet joints preserve existing bony structures and therefore do not address pathologies that affect facet joints themselves. Certain facet joint prostheses, such as those disclosed in U.S. Pat. No. 6,132,464, are intended to be supported on the lamina or the posterior arch. As the lamina is a very complex and highly variable anatomical structure, it is very difficult to design a prosthesis that provides reproducible positioning against the lamina to correctly locate the prosthetic facet joints. In addition, when facet joint replacement involves complete removal and replacement of the natural facet joint, as disclosed in U.S. Pat. No. 6,579,319, the prosthesis is unlikely to endure the loads and cycling experienced by the vertebra. Thus, the facet joint replacement may be subject to long-term displacement. Furthermore, when facet joint disorders are accompanied by disease or trauma to other structures of a vertebra (such as the lamina, spinous process, and/or transverse processes) facet joint replacement is insufficient to treat the problem(s).
Most recently, surgical-based technologies, referred to as “dynamic posterior stabilization,” have been developed to address spinal pain resulting from more than one disorder, when more than one structure of the spine have been compromised. An objective of such technologies is to provide the support of fusion-based implants while maximizing the natural biomechanics of the spine. Dynamic posterior stabilization systems typically fall into one of two general categories: posterior pedicle screw-based systems and interspinous spacers.
Examples of pedicle screw-based systems are disclosed in U.S. Pat. Nos. 5,015,247, 5,484,437, 5,489,308, 5,609,636 and 5,658,337, 5,741,253, 6,080,155, 6,096,038, 6,264,656 and 6,270,498. These types of systems involve the use of screws that are positioned in the vertebral body through the pedicle. Certain types of these pedicle screw-based systems may be used to augment compromised facet joints, while others require removal of the spinous process and/or the facet joints for implantation. One such system, the Zimmer Spine Dynesys® employs a cord which is extended between the pedicle screws and a fairly rigid spacer which is passed over the cord and positioned between the screws. While this system is able to provide load sharing and restoration of disc height, because it is so rigid, it does not effective in preserving the natural motion of the spinal segment into which it is implanted. Other pedicle screw-based systems employ articulating joints between the pedicle screws. Because these types of systems require the use of pedicle screws, implantation of the systems are often more invasive to implant than interspinous spacers.
Where the level of disability or pain to the affected spinal motion segments is not that severe or where the condition, such as an injury, is not chronic, the use of interspinous spacers are preferred over pedicle based systems as they require a less invasive implantation approach and less dissection of the surrounding tissue and ligaments. Examples of interspinous spacers are disclosed in U.S. Pat. Nos. Re. 36,211, 5,645,599, 6,149,642, 6,500,178, 6,695,842, 6,716,245 and 6,761,720. The spacers, which are made of either a hard or compliant material, are placed in between adjacent spinous processes. The harder material spacers are fixed in place by means of the opposing force caused by distracting the affected spinal segment and/or by use of keels or screws that anchor into the spinous process. While slightly less invasive than the procedures required for implanting a pedicle screw-based dynamic stabilization system, implantation of hard or solid interspinous spacers still requires dissection of muscle tissue and of the supraspinous and interspinous ligaments. Additionally, these tend to facilitate spinal motion that is less analogous to the natural spinal motion than do the more compliant and flexible interspinous spacers. Another advantage of the compliant/flexible interspinous spacers is the ability to deliver them somewhat less invasively than those that are not compliant or flexible; however, their compliancy makes them more susceptible to displacement or migration over time. To obviate this risk, many of these spacers employ straps or the like that are wrapped around the spinous processes of the vertebrae above and below the level where the spacer is implanted. Of course, this requires some additional tissue and ligament dissection superior and inferior to the implant site, i.e., at least within the adjacent interspinous spaces.
With the limitations of current spine stabilization technologies, there is clearly a need for an improved means and method for dynamic posterior stabilization of the spine that address the drawbacks of prior devices. In particular, it would be highly beneficial to have a dynamic stabilization system that involves a minimally invasive implantation procedure, where the extent of distraction between the affected vertebrae is adjustable upon implantation and at a later time if necessary. It would be additionally advantageous if the system or device was also removable in a minimally invasive manner.
The present invention provides devices, systems and methods for stabilizing at least one spinal motion segment. The stabilizing devices include an expandable spacer or member having an unexpanded configuration and an expanded configuration, wherein the expandable member in an expanded configuration has a size, volume, diameter, length, cross-section and/or shape configured for positioning between the spinous processes of adjacent vertebrae in order to distract the vertebrae relative to each other.
In certain embodiments, the expandable member is a helical body having a varying cross-section along its longitudinal axis, such that compression, squeezing, or other longitudinal translation of the helical body causes the helical body to expand in at least one direction. When placed between two spinous processes, the expansion allows support and stabilization of the processes relative to each other.
The stabilizing devices may be configured such that the transformation from the low-profile state to the high-profile state is immediate or gradual, where the extent of expansion is controllable. The transformation may occur in one-step or evolve in continuous fashion where at least one of volume, shape, size, diameter, length, etc. is continually changing until the desired expansion end point is achieved. This transformation may be reversible such that after implantation, the stabilizing device may be partially or completely unexpanded, collapsed, deflated or at least reduced in size, volume, etc. in order to facilitate removal of the member from the implant site or to facilitate adjustment or repositioning of the member in vivo.
The stabilizing devices may be configured to stay stationary in the implant site on their own (or “float”) or may be further fixed or anchored to surrounding tissue, e.g., bone (e.g., spinous processes, vertebrae), muscle, ligaments or other soft tissue, to ensure against migration of the implant. In their final deployed state, the stabilizing devices may be flexible to allow some degree of extension of the spine or may otherwise be rigid so as prevent extension altogether. Optionally, the devices may include one or more markers on a surface of the expandable member to facilitate fluoroscopic imaging.
The invention further includes methods for stabilizing at least one spinal motion segment which involve the implantation of one or more devices or expandable spacers of the present invention, in which the expandable member is positioned between the spinous processes of adjacent vertebrae in an unexpanded or undeployed condition and then subsequently expanded or deployed to a size and/or shape for selectively distracting the adjacent vertebrae. The invention also contemplates the temporary implantation of the subject devices which may be subsequently removed from the patient once the intended treatment is complete. The methods may also include adjustment of the implants in vivo.
Many of the methods involve the percutaneous implantation of the subject devices from either an ipsolateral approach or a mid-line approach into the interspinous space. Certain methods involve the delivery of certain components by a lateral approach and other components by a mid-line approach. The implantation methods may involve the use of cannulas through which the stabilizing devices are delivered into an implant site, however, such may not be required, with the stabilizing devices be configured to pass directly through an incision.
These and other objects, advantages, and features of the invention will become apparent to those persons skilled in the art upon reading the details of the invention as more fully described below.
The invention is best understood from the following detailed description when read in conjunction with the accompanying drawings. It is emphasized that, according to common practice, the various features of the drawings are not to-scale. On the contrary, the dimensions of the various features are arbitrarily expanded or reduced for clarity. Included in the drawings are the following figures:
Before the subject devices, systems and methods are described, it is to be understood that this invention is not limited to particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present invention will be limited only by the appended claims.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
It must be noted that as used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a spinal segment” may include a plurality of such spinal segments and reference to “the screw” includes reference to one or more screw and equivalents thereof known to those skilled in the art, and so forth.
Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limits of that range is also specifically disclosed. Each smaller range between any stated value or intervening value in a stated range and any other stated or intervening value in that stated range is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range, and each range where either, neither or both limits are included in the smaller ranges is also encompassed within the invention, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the invention.
All publications mentioned herein are incorporated herein by reference to disclose and describe the methods and/or materials in connection with which the publications are cited. The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present invention is not entitled to antedate such publication by virtue of prior invention. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.
The present invention will now be described in greater detail by way of the following description of exemplary embodiments and variations of the devices and methods of the present invention. The invention generally includes an interspinous spacer device as well as instruments for the percutaneous implantation of the interspinous spacer. A key feature of the interspinous spacer device is that it is expandable from a low profile configuration to a higher profile or operative configuration. This design allows the device, when in the low profile condition, to be delivered by percutaneous means without requiring the removal of any portion of the spinal motion segment into which the device is implanted.
Referring now to the drawings and to
The interspinous device 10 includes a distal end 11 and a proximal end (not shown). At the distal end 11 is disposed a tip 12, which may be made of a biocompatible material such as polymers, metals, nitinol, etc. The expandable member 14 has a distal end 22 and a proximal end 18, with the distal end 22 adjacent the tip 12 and the proximal end 18 adjacent a delivery shaft 16. Interior of the delivery shaft 16 and the expandable member 14, and coupled to tip 12, is a central shaft 24.
The expandable spacer body 14 is generally formed by a helical body having a cross-sectional shape that varies along at least a portion of a longitudinal axis such that longitudinal translation of the proximal end 18 towards the distal end 22, or vice-versa or both, effectively squeezing the expandable spacer body 14 in a longitudinal fashion, causes portions of the expandable spacer body 14 to expand to provide a spacer support between the spinous processes. In particular, various portions of the expandable spacer body 14 expand in a radial dimension from a value r0 to a value r>r0, up to a maximum value of rmax. In certain embodiments, the axial dimension of the expandable spacer body in the undeployed configuration is greater than that in the deployed configuration.
The distal end 22 of the expandable spacer body may be affixed to the tip 12 and to the central shaft 24 such that a sliding longitudinal translation of the proximal end 18 over the central shaft leads to expansion. Various other combinations of affixations and sliding members may also be employed. In general, the longitudinal translation over a distance x leads to expansion of the expandable spacer body 14.
The expandable spacer body 14 is made of a biocompatible material such as a non-porous material, e.g., nitinol, polymers, or titanium. The shaft 16 may be made of various biocompatible materials, including titanium, stainless steel, etc. The spacer body and/or the shaft may be coated with a lubricious coating or other such treatment to facilitate sliding. These may include, e.g., Teflon®, silicone, surface energy treatments, etc.
As noted above, translation of the proximal and distal ends towards each other leads to radial expansion of portions of the expandable spacer body 14. In more detail, the expandable spacer body 14 is formed of a helical body. The cross-section of the helical body changes to cause the expansion upon longitudinal translation. Referring in particular to
Of course, it is noted that these elements reflect cross-sections that in an actual device may be continuously changing along the helix. For clarity, these two-dimensional cross-sections are discussed here, with the understanding that they refer to a three-dimensional helical structure that may be continuously changing in cross-section. For example, portions of the helical body between segments 14b and 14c emerge above the plane of the page and descend below the plane of the page. These portions may have cross-sectional shapes that are the same as or different than that of segments 14b and 14c. In general, they may be close to the same, and may be shaped in a fashion intermediate to that of 14b and 14c.
In an unexpanded configuration, all segments 14a-14n may have substantially the same radius r0. In an expanded configuration, as shown in
While the general system of variation of cross-sections depends on the usage and geometry of the desired spacer, some general rules may apply in certain embodiments, but it should be especially noted that these do not apply to all systems. First, 14i may be closer or more similar in shape to 14j than the same is to 14a or 14n. Next, if 14a has a distal edge that is at an angle θa1 and a proximal edge that is at an angle θa2, then θa1 and θn2 may be equal to zero. If θb1 up to θmax1, i.e., angles distal of segment 14max, are considered to have a positive value of angle, then θmax2 up up to θn1, i.e., angles proximal to segment 14max, may be considered to have a negative value of angle. For the segment with the maximal radial dimension, 14max, its distal edge may have an angle with opposite sign to that of its proximal edge. It is noted again that these are general statements that hold for certain embodiments but do not hold for others.
It is additionally noted that the embodiment of
Referring to
As one example, referring to
A fixed segment or threaded module 26 is provided which the threaded segment may be rotated against to, e.g., pull the distal tip toward the proximal end to deploy the spacer. In an alternative embodiment, a balloon or other such expandable member within the device may be employed to expand the same in the absence of a compressional force. A “filler” material can be disposed within the helical spacer body to maintain the expansion. This may include compressible materials such as elastomers or uncompressible materials such as cements. A locking mechanism may be similarly employed, and the locking may be permanent or reversible. In a related embodiment, the locking may allow a limited range of translation, including translation after the device is implanted, to accommodate movement, loads, etc.
The device may be afforded a capability to reposition the same following implantation, and this reposition may be done in a minimally-invasive manner. For example, a tool may be percutaneously placed to engage the compression assembly, e.g., to turn the screw, or to provide additional compression or tension which corresponds to additional radial expansion or contraction.
In an alternative embodiment, as shown in
Referring to
Referring to
It should be noted that while a helical body is shown, the same is not required in certain embodiments of the invention. For example, as shown in
In certain embodiments, the expandable body is made of a non-compliant or semi-compliant material so as to maintain a substantially fixed shape or configuration and ensure proper, long-term retention within the implant site. In other embodiments, the expandable member may be made of a compliant material. In any embodiment, the compressibility and flexibility of can be selected to address the indications being treated.
In certain embodiments of present invention, either during the implant procedure or in a subsequent procedure, the size or volume of the implanted expandable spacer may be selectively adjusted or varied. For example, after an initial assessment upon implant, it may be necessary to adjust, either reduce or increase, the size or volume of the spacer to optimize the intended treatment. Further, it may be intended to only temporarily implant the spacer for the purpose of treating a temporary condition, e.g., an injured or bulging or herniated disk. Once the repair is achieved or the treatment completed, the spacer may be removed, either with or without substantially reducing the size or volume of the spacer. In other embodiments, the spacer may be made of biodegradable materials wherein the spacer degrades after a time in which the injury is healed or the treatment completed.
When unexpanded or deflated, as shown in
The device may further include radiopaque markers on the surface of the expandable body 14 visible under fluoroscopic imaging to facilitate positioning of the expandable body. Any number of markers may be employed anywhere on the expandable body 14, or the helical body itself may be radiopaque. Other markers may also be employed, including ultrasound markers. Any of the markers described, or other such markers, may be employed to determine the level of deployment or the sufficiency of deployment. For example, two markers may be disposed on the device such that if the markers are seen to be in a particular alignment, the device is considered to be fully deployed. One of ordinary skill in the art given this teaching will see numerous other ways in which the use of markers can provide significant information about the position, orientation, and deployment of the device.
Once installed, the interspinous device may be further secured to the spinous processes 18, 22 to ensure that the expandable body does not slip or migrate from its implanted position. Any type of anchoring means, such as screws, tacks, staples, adhesive, etc. may be employed. The delivery shaft 16 may be removed from the expandable spacer body 14 using devices and techniques disclosed in the patent application incorporated by reference above.
The subject devices and systems may be provided in the form of a kit which includes at least one interspinous device of the present invention. A plurality of such devices may be provided where the devices have the same or varying sizes and shapes and are made of the same or varying biocompatible materials. Possible biocompatible materials include polymers, plastics, ceramic, metals, e.g., titanium, stainless steel, tantalum, chrome cobalt alloys, etc. The kits may further include instruments and tools for implanting the subject devices, including but not limited to, a cannula, a trocar, a scope, a device delivery/inflation/expansion lumen, a cutting instrument, a screw driver, etc., as well as a selection of screws or other devices for anchoring the spacer to the spinous processes. Instructions for implanting the interspinous spacers and using the above-described instrumentation may also be provided with the kits.
The preceding merely illustrates the principles of the invention. It will be appreciated that those skilled in the art will be able to devise various arrangements which, although not explicitly described or shown herein, embody the principles of the invention and are included within its spirit and scope. Furthermore, all examples and conditional language recited herein are principally intended to aid the reader in understanding the principles of the invention and the concepts contributed by the inventors to furthering the art, and are to be construed as being without limitation to such specifically recited examples and conditions. Moreover, all statements herein reciting principles, aspects, and embodiments of the invention as well as specific examples thereof, are intended to encompass both structural and functional equivalents thereof. Additionally, it is intended that such equivalents include both currently known equivalents and equivalents developed in the future, i.e., any elements developed that perform the same function, regardless of structure. The scope of the present invention, therefore, is not intended to be limited to the exemplary embodiments shown and described herein. Rather, the scope and spirit of present invention is embodied by the appended claims.
This application is a continuation of U.S. patent application Ser. No. 11/305,820, filed on Dec. 15, 2005; which is a continuation-in-part of U.S. patent application Ser. No. 11/190,496, filed on Jul. 26, 2005; which is a continuation-in-part of U.S. patent application Ser. No. 11/079,006, filed on Mar. 10, 2005; which is a continuation-in-part of U.S. patent application Ser. No. 11/052,002 filed on Feb. 4, 2005; which is a continuation-in-part of U.S. patent application Ser. No. 11/006,502 filed on Dec. 6, 2004; which is a continuation-in-part of U.S. patent application Ser. No. 10/970,843 filed on Oct. 20, 2004; all of the above are incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
2248054 | Becker | Jul 1941 | A |
2677369 | Knowles | May 1954 | A |
3242120 | Steuber | Mar 1966 | A |
3648691 | Lumb et al. | Mar 1972 | A |
3986383 | Petteys | Oct 1976 | A |
4632101 | Freedland | Dec 1986 | A |
4685447 | Iversen et al. | Aug 1987 | A |
4863476 | Shepperd | Sep 1989 | A |
4895564 | Farrell | Jan 1990 | A |
5011484 | Breard et al. | Apr 1991 | A |
5015247 | Michelson | May 1991 | A |
5019081 | Watanabe | May 1991 | A |
5059193 | Kuslich | Oct 1991 | A |
5092866 | Breard et al. | Mar 1992 | A |
5180393 | Commarmond et al. | Jan 1993 | A |
5182281 | Frigola-Constansa et al. | Jan 1993 | A |
5188281 | Fujiwara et al. | Feb 1993 | A |
5192281 | de la Caffiniere | Mar 1993 | A |
5195526 | Michelson | Mar 1993 | A |
5298253 | LeFiles et al. | Mar 1994 | A |
5368594 | Martin et al. | Nov 1994 | A |
5390683 | Pisharodi | Feb 1995 | A |
5415661 | Holmes | May 1995 | A |
5456722 | McLeod et al. | Oct 1995 | A |
5462738 | LeFiles et al. | Oct 1995 | A |
5472452 | Trott | Dec 1995 | A |
5484437 | Michelson | Jan 1996 | A |
5487739 | Aebischer et al. | Jan 1996 | A |
5489308 | Kuslich et al. | Feb 1996 | A |
5496318 | Howland et al. | Mar 1996 | A |
5531748 | de la Caffiniere et al. | Jul 1996 | A |
5549679 | Kuslich | Aug 1996 | A |
5571189 | Kuslich | Nov 1996 | A |
5591165 | Jackson | Jan 1997 | A |
5609634 | Voydeville et al. | Mar 1997 | A |
5609636 | Kohrs et al. | Mar 1997 | A |
5645599 | Samani et al. | Jul 1997 | A |
5654599 | Casper | Aug 1997 | A |
5658337 | Kohrs et al. | Aug 1997 | A |
5674295 | Ray et al. | Oct 1997 | A |
5700264 | Zucherman et al. | Dec 1997 | A |
5725582 | Bevan et al. | Mar 1998 | A |
5741253 | Michelson | Apr 1998 | A |
5762629 | Kambin | Jun 1998 | A |
5836948 | Zucherman et al. | Nov 1998 | A |
5860977 | Zucherman et al. | Jan 1999 | A |
5863948 | Epstein et al. | Jan 1999 | A |
5876404 | Zucherman et al. | Mar 1999 | A |
RE36211 | Nonomura | May 1999 | E |
5904636 | Chen et al. | May 1999 | A |
5904686 | Zucherman et al. | May 1999 | A |
5972015 | Scribner et al. | Oct 1999 | A |
6039761 | Li et al. | Mar 2000 | A |
6045552 | Zucherman et al. | Apr 2000 | A |
6048342 | Zucherman et al. | Apr 2000 | A |
6066154 | Reiley et al. | May 2000 | A |
6068630 | Zucherman et al. | May 2000 | A |
6074390 | Zucherman et al. | Jun 2000 | A |
6080155 | Michelson | Jun 2000 | A |
6080157 | Cathro et al. | Jun 2000 | A |
6090112 | Zucherman et al. | Jul 2000 | A |
6096038 | Michelson | Aug 2000 | A |
6102928 | Bonutti | Aug 2000 | A |
D433193 | Gaw et al. | Oct 2000 | S |
6132464 | Martin et al. | Oct 2000 | A |
6149642 | Gerhart et al. | Nov 2000 | A |
6149652 | Zucherman et al. | Nov 2000 | A |
6152926 | Zucherman et al. | Nov 2000 | A |
6156038 | Zucherman et al. | Dec 2000 | A |
6159215 | Urbahns et al. | Dec 2000 | A |
6179873 | Zientek | Jan 2001 | B1 |
6183471 | Zucherman et al. | Feb 2001 | B1 |
6190387 | Zucherman et al. | Feb 2001 | B1 |
6225048 | Soderberg-Naucler et al. | May 2001 | B1 |
6235030 | Zucherman et al. | May 2001 | B1 |
6238397 | Zucherman et al. | May 2001 | B1 |
6264651 | Underwood et al. | Jul 2001 | B1 |
6264656 | Michelson | Jul 2001 | B1 |
6267765 | Taylor et al. | Jul 2001 | B1 |
6270498 | Michelson | Aug 2001 | B1 |
6280444 | Zucherman et al. | Aug 2001 | B1 |
6312431 | Asfora | Nov 2001 | B1 |
6332882 | Zucherman et al. | Dec 2001 | B1 |
6332883 | Zucherman et al. | Dec 2001 | B1 |
6336930 | Stalcup et al. | Jan 2002 | B1 |
6348053 | Cachia | Feb 2002 | B1 |
6364883 | Santilli | Apr 2002 | B1 |
6371989 | Chauvin et al. | Apr 2002 | B1 |
6375682 | Fleischmann et al. | Apr 2002 | B1 |
6379355 | Zucherman et al. | Apr 2002 | B1 |
6395032 | Gauchet et al. | May 2002 | B1 |
6402740 | Ellis et al. | Jun 2002 | B1 |
6402750 | Atkinson et al. | Jun 2002 | B1 |
6402784 | Wardlaw et al. | Jun 2002 | B1 |
6413228 | Hung et al. | Jul 2002 | B1 |
6419676 | Zucherman et al. | Jul 2002 | B1 |
6419677 | Zucherman et al. | Jul 2002 | B2 |
6440169 | Elberg et al. | Aug 2002 | B1 |
6443988 | Felt et al. | Sep 2002 | B2 |
6447547 | Michelson | Sep 2002 | B1 |
6451019 | Zucherman et al. | Sep 2002 | B1 |
6451020 | Zucherman et al. | Sep 2002 | B1 |
6471976 | Taylor et al. | Oct 2002 | B1 |
6478796 | Zucherman et al. | Nov 2002 | B2 |
6478822 | Leroux et al. | Nov 2002 | B1 |
6500178 | Zucherman et al. | Dec 2002 | B2 |
6514256 | Zucherman et al. | Feb 2003 | B2 |
6530925 | Boudard et al. | Mar 2003 | B2 |
6558333 | Gilboa et al. | May 2003 | B2 |
6565570 | Sterett et al. | May 2003 | B2 |
6572617 | Senegas et al. | Jun 2003 | B1 |
6575981 | Boyd et al. | Jun 2003 | B1 |
6579319 | Goble et al. | Jun 2003 | B2 |
6582433 | Yun | Jun 2003 | B2 |
6582451 | Marucci et al. | Jun 2003 | B1 |
6610065 | Branch et al. | Aug 2003 | B1 |
6610091 | Reiley | Aug 2003 | B1 |
6626944 | Taylor et al. | Sep 2003 | B1 |
6645207 | Dixon et al. | Nov 2003 | B2 |
6645211 | Magana | Nov 2003 | B2 |
6652527 | Zucherman et al. | Nov 2003 | B2 |
6652534 | Zucherman et al. | Nov 2003 | B2 |
6679886 | Weikel et al. | Jan 2004 | B2 |
6695842 | Zucherman et al. | Feb 2004 | B2 |
6699246 | Zucherman et al. | Mar 2004 | B2 |
6699247 | Zucherman et al. | Mar 2004 | B2 |
6712819 | Zucherman et al. | Mar 2004 | B2 |
6716245 | Pasquet et al. | Apr 2004 | B2 |
6733534 | Sherman | May 2004 | B2 |
6746485 | Zucherman et al. | Jun 2004 | B1 |
6761720 | Senegas et al. | Jul 2004 | B1 |
6769983 | Slomiany | Aug 2004 | B2 |
6783529 | Hover et al. | Aug 2004 | B2 |
6783546 | Zucherman et al. | Aug 2004 | B2 |
6796983 | Zucherman et al. | Sep 2004 | B1 |
6835205 | Atkinson et al. | Dec 2004 | B2 |
6858029 | Yeh et al. | Feb 2005 | B2 |
6869398 | Obenchain et al. | Mar 2005 | B2 |
6875212 | Shaolian et al. | Apr 2005 | B2 |
6902566 | Zucherman et al. | Jun 2005 | B2 |
6926728 | Zucherman et al. | Aug 2005 | B2 |
6946000 | Senegas et al. | Sep 2005 | B2 |
6949123 | Reiley | Sep 2005 | B2 |
6966930 | Arnin et al. | Nov 2005 | B2 |
6974478 | Reiley et al. | Dec 2005 | B2 |
7011685 | Arnin et al. | Mar 2006 | B2 |
7029473 | Zucherman et al. | Apr 2006 | B2 |
7033358 | Taylor et al. | Apr 2006 | B2 |
7048736 | Robinson et al. | May 2006 | B2 |
7070598 | Lim et al. | Jul 2006 | B2 |
7083649 | Zucherman et al. | Aug 2006 | B2 |
7087055 | Lim et al. | Aug 2006 | B2 |
7087083 | Pasquet et al. | Aug 2006 | B2 |
7097648 | Globerman et al. | Aug 2006 | B1 |
7101375 | Zucherman et al. | Sep 2006 | B2 |
7163558 | Senegas et al. | Jan 2007 | B2 |
7179225 | Shluzas et al. | Feb 2007 | B2 |
7187064 | Tzu et al. | Mar 2007 | B2 |
7189234 | Zucherman et al. | Mar 2007 | B2 |
7189236 | Taylor et al. | Mar 2007 | B2 |
7201751 | Zucherman et al. | Apr 2007 | B2 |
7217291 | Zucherman et al. | May 2007 | B2 |
7223289 | Trieu et al. | May 2007 | B2 |
7229441 | Trieu et al. | Jun 2007 | B2 |
7238204 | Le Couedic et al. | Jul 2007 | B2 |
7252673 | Lim | Aug 2007 | B2 |
7273496 | Mitchell | Sep 2007 | B2 |
7282063 | Cohen et al. | Oct 2007 | B2 |
7297162 | Mujwid | Nov 2007 | B2 |
7306628 | Zucherman et al. | Dec 2007 | B2 |
7318839 | Malberg et al. | Jan 2008 | B2 |
7320707 | Zucherman et al. | Jan 2008 | B2 |
7335200 | Carli | Feb 2008 | B2 |
7335203 | Winslow et al. | Feb 2008 | B2 |
7354453 | McAfee | Apr 2008 | B2 |
7384340 | Eguchi et al. | Jun 2008 | B2 |
7410501 | Michelson | Aug 2008 | B2 |
7442208 | Mathieu et al. | Oct 2008 | B2 |
7445637 | Taylor | Nov 2008 | B2 |
7473268 | Zucherman et al. | Jan 2009 | B2 |
7476251 | Zucherman et al. | Jan 2009 | B2 |
7481839 | Zucherman et al. | Jan 2009 | B2 |
7481840 | Zucherman et al. | Jan 2009 | B2 |
7491204 | Marnay et al. | Feb 2009 | B2 |
7497859 | Zucherman et al. | Mar 2009 | B2 |
7503935 | Zucherman et al. | Mar 2009 | B2 |
7504798 | Kawada et al. | Mar 2009 | B2 |
7510567 | Zucherman et al. | Mar 2009 | B2 |
7520887 | Maxy et al. | Apr 2009 | B2 |
7520899 | Zucherman et al. | Apr 2009 | B2 |
7547308 | Bertagnoli et al. | Jun 2009 | B2 |
7549999 | Zucherman et al. | Jun 2009 | B2 |
7550009 | Arnin et al. | Jun 2009 | B2 |
7565259 | Sheng et al. | Jul 2009 | B2 |
7572276 | Lim et al. | Aug 2009 | B2 |
7575600 | Zucherman et al. | Aug 2009 | B2 |
7585313 | Kwak et al. | Sep 2009 | B2 |
7585316 | Trieu | Sep 2009 | B2 |
7588588 | Spitler et al. | Sep 2009 | B2 |
7591851 | Winslow et al. | Sep 2009 | B2 |
7601170 | Winslow et al. | Oct 2009 | B2 |
7621939 | Zucherman et al. | Nov 2009 | B2 |
7635377 | Zucherman et al. | Dec 2009 | B2 |
7635378 | Zucherman et al. | Dec 2009 | B2 |
7637950 | Baccelli et al. | Dec 2009 | B2 |
7658752 | Labrom et al. | Feb 2010 | B2 |
7662187 | Zucherman et al. | Feb 2010 | B2 |
7666209 | Zucherman et al. | Feb 2010 | B2 |
7666228 | Le Couedic et al. | Feb 2010 | B2 |
7670377 | Zucherman et al. | Mar 2010 | B2 |
7682376 | Trieu | Mar 2010 | B2 |
7691146 | Zucherman et al. | Apr 2010 | B2 |
7695513 | Zucherman et al. | Apr 2010 | B2 |
7699852 | Frankel et al. | Apr 2010 | B2 |
7699873 | Stevenson et al. | Apr 2010 | B2 |
7727233 | Blackwell et al. | Jun 2010 | B2 |
7742795 | Stone et al. | Jun 2010 | B2 |
7749252 | Zucherman et al. | Jul 2010 | B2 |
7749253 | Zucherman et al. | Jul 2010 | B2 |
7753938 | Aschmann et al. | Jul 2010 | B2 |
7758619 | Zucherman et al. | Jul 2010 | B2 |
7758647 | Arnin et al. | Jul 2010 | B2 |
7763028 | Lim et al. | Jul 2010 | B2 |
7763050 | Winslow et al. | Jul 2010 | B2 |
7763051 | Labrom et al. | Jul 2010 | B2 |
7763073 | Hawkins et al. | Jul 2010 | B2 |
7763074 | Altarac et al. | Jul 2010 | B2 |
7766967 | Francis | Aug 2010 | B2 |
7776090 | Winslow et al. | Aug 2010 | B2 |
7780709 | Bruneau et al. | Aug 2010 | B2 |
7789898 | Peterman | Sep 2010 | B2 |
7794476 | Wisnewski | Sep 2010 | B2 |
7803190 | Zucherman et al. | Sep 2010 | B2 |
7806911 | Peckham | Oct 2010 | B2 |
7811308 | Arnin et al. | Oct 2010 | B2 |
7811322 | Arnin et al. | Oct 2010 | B2 |
7811323 | Arnin et al. | Oct 2010 | B2 |
7811324 | Arnin et al. | Oct 2010 | B2 |
7811330 | Arnin et al. | Oct 2010 | B2 |
7819921 | Grotz | Oct 2010 | B2 |
7828822 | Zucherman et al. | Nov 2010 | B2 |
7828849 | Lim | Nov 2010 | B2 |
7833272 | Arnin et al. | Nov 2010 | B2 |
7837688 | Boyer, II et al. | Nov 2010 | B2 |
7837711 | Bruneau et al. | Nov 2010 | B2 |
7837734 | Zucherman et al. | Nov 2010 | B2 |
7846183 | Blain | Dec 2010 | B2 |
7846185 | Carls et al. | Dec 2010 | B2 |
7846186 | Taylor | Dec 2010 | B2 |
7857815 | Zucherman et al. | Dec 2010 | B2 |
7862569 | Zucherman et al. | Jan 2011 | B2 |
7862586 | Malek | Jan 2011 | B2 |
7862590 | Lim et al. | Jan 2011 | B2 |
7862592 | Peterson et al. | Jan 2011 | B2 |
7862615 | Carli et al. | Jan 2011 | B2 |
7867276 | Matge et al. | Jan 2011 | B2 |
7871426 | Chin et al. | Jan 2011 | B2 |
8292922 | Altarac et al. | Oct 2012 | B2 |
20010031965 | Zucherman et al. | Oct 2001 | A1 |
20020143331 | Zucherman et al. | Oct 2002 | A1 |
20030040746 | Mitchell et al. | Feb 2003 | A1 |
20030074075 | Thomas et al. | Apr 2003 | A1 |
20030149438 | Nichols et al. | Aug 2003 | A1 |
20030153976 | Cauthen et al. | Aug 2003 | A1 |
20030176921 | Lawson | Sep 2003 | A1 |
20030220643 | Ferree | Nov 2003 | A1 |
20030220650 | Major et al. | Nov 2003 | A1 |
20040087947 | Lim et al. | May 2004 | A1 |
20040167625 | Beyar et al. | Aug 2004 | A1 |
20040220568 | Zucherman et al. | Nov 2004 | A1 |
20050049708 | Atkinson et al. | Mar 2005 | A1 |
20050075634 | Zucherman et al. | Apr 2005 | A1 |
20050101955 | Zucherman et al. | May 2005 | A1 |
20050125066 | McAfee | Jun 2005 | A1 |
20050143738 | Zucherman et al. | Jun 2005 | A1 |
20050165398 | Reiley | Jul 2005 | A1 |
20050182416 | Lim et al. | Aug 2005 | A1 |
20050192586 | Zucherman et al. | Sep 2005 | A1 |
20050192671 | Bao et al. | Sep 2005 | A1 |
20050209603 | Zucherman et al. | Sep 2005 | A1 |
20050216087 | Zucherman et al. | Sep 2005 | A1 |
20050228383 | Zucherman et al. | Oct 2005 | A1 |
20050228384 | Zucherman et al. | Oct 2005 | A1 |
20050228426 | Campbell | Oct 2005 | A1 |
20050245937 | Winslow | Nov 2005 | A1 |
20050278028 | Mujwid | Dec 2005 | A1 |
20060036258 | Zucherman et al. | Feb 2006 | A1 |
20060064165 | Zucherman et al. | Mar 2006 | A1 |
20060064166 | Zucherman et al. | Mar 2006 | A1 |
20060074431 | Sutton et al. | Apr 2006 | A1 |
20060084976 | Borgstrom et al. | Apr 2006 | A1 |
20060084983 | Kim | Apr 2006 | A1 |
20060084985 | Kim | Apr 2006 | A1 |
20060084988 | Kim | Apr 2006 | A1 |
20060084991 | Borgstrom et al. | Apr 2006 | A1 |
20060085069 | Kim | Apr 2006 | A1 |
20060085070 | Kim | Apr 2006 | A1 |
20060085074 | Raiszadeh | Apr 2006 | A1 |
20060089718 | Zucherman et al. | Apr 2006 | A1 |
20060102269 | Uchida et al. | May 2006 | A1 |
20060122620 | Kim | Jun 2006 | A1 |
20060149254 | Lauryssen et al. | Jul 2006 | A1 |
20060149289 | Winslow et al. | Jul 2006 | A1 |
20060167416 | Mathis et al. | Jul 2006 | A1 |
20060195102 | Malandain | Aug 2006 | A1 |
20060217811 | Lambrecht et al. | Sep 2006 | A1 |
20060224159 | Anderson | Oct 2006 | A1 |
20060235386 | Anderson | Oct 2006 | A1 |
20060241597 | Mitchell et al. | Oct 2006 | A1 |
20060241614 | Bruneau et al. | Oct 2006 | A1 |
20060241757 | Anderson | Oct 2006 | A1 |
20060247623 | Anderson et al. | Nov 2006 | A1 |
20060247632 | Winslow et al. | Nov 2006 | A1 |
20060247633 | Winslow et al. | Nov 2006 | A1 |
20060247650 | Yerby et al. | Nov 2006 | A1 |
20060247773 | Stamp | Nov 2006 | A1 |
20060264938 | Zucherman et al. | Nov 2006 | A1 |
20060264939 | Zucherman et al. | Nov 2006 | A1 |
20060265066 | Zucherman et al. | Nov 2006 | A1 |
20060265067 | Zucherman et al. | Nov 2006 | A1 |
20060271049 | Zucherman et al. | Nov 2006 | A1 |
20060271055 | Thramann | Nov 2006 | A1 |
20060271061 | Beyar et al. | Nov 2006 | A1 |
20060271194 | Zucherman et al. | Nov 2006 | A1 |
20060276801 | Yerby et al. | Dec 2006 | A1 |
20060276897 | Winslow et al. | Dec 2006 | A1 |
20060282077 | Labrom et al. | Dec 2006 | A1 |
20060282078 | Labrom et al. | Dec 2006 | A1 |
20070016196 | Winslow et al. | Jan 2007 | A1 |
20070055237 | Edidin et al. | Mar 2007 | A1 |
20070055246 | Zucherman et al. | Mar 2007 | A1 |
20070073289 | Kwak et al. | Mar 2007 | A1 |
20070100340 | Lange et al. | May 2007 | A1 |
20070123863 | Winslow et al. | May 2007 | A1 |
20070123904 | Stad et al. | May 2007 | A1 |
20070161991 | Altarac et al. | Jul 2007 | A1 |
20070161993 | Lowery et al. | Jul 2007 | A1 |
20070173818 | Hestad et al. | Jul 2007 | A1 |
20070173821 | Trieu | Jul 2007 | A1 |
20070173822 | Bruneau et al. | Jul 2007 | A1 |
20070173823 | Dewey et al. | Jul 2007 | A1 |
20070173832 | Tebbe et al. | Jul 2007 | A1 |
20070173939 | Kim et al. | Jul 2007 | A1 |
20070179500 | Chin et al. | Aug 2007 | A1 |
20070185490 | Implicito | Aug 2007 | A1 |
20070191948 | Arnin et al. | Aug 2007 | A1 |
20070198045 | Morton et al. | Aug 2007 | A1 |
20070198091 | Boyer et al. | Aug 2007 | A1 |
20070203493 | Zucherman et al. | Aug 2007 | A1 |
20070203495 | Zucherman et al. | Aug 2007 | A1 |
20070203496 | Zucherman et al. | Aug 2007 | A1 |
20070203497 | Zucherman et al. | Aug 2007 | A1 |
20070203501 | Zucherman et al. | Aug 2007 | A1 |
20070208345 | Marnay et al. | Sep 2007 | A1 |
20070208346 | Marnay et al. | Sep 2007 | A1 |
20070208366 | Pellegrino et al. | Sep 2007 | A1 |
20070225706 | Clark et al. | Sep 2007 | A1 |
20070225724 | Edmond | Sep 2007 | A1 |
20070225807 | Phan et al. | Sep 2007 | A1 |
20070225814 | Atkinson et al. | Sep 2007 | A1 |
20070233068 | Bruneau et al. | Oct 2007 | A1 |
20070233074 | Anderson et al. | Oct 2007 | A1 |
20070233076 | Trieu | Oct 2007 | A1 |
20070233077 | Khalili | Oct 2007 | A1 |
20070233081 | Pasquet et al. | Oct 2007 | A1 |
20070233082 | Chin et al. | Oct 2007 | A1 |
20070233083 | Abdou | Oct 2007 | A1 |
20070233084 | Betz et al. | Oct 2007 | A1 |
20070233088 | Edmond | Oct 2007 | A1 |
20070233089 | DiPoto et al. | Oct 2007 | A1 |
20070233096 | Garcia-Bengochea | Oct 2007 | A1 |
20070233098 | Mastrorio et al. | Oct 2007 | A1 |
20070233129 | Bertagnoli et al. | Oct 2007 | A1 |
20070250060 | Anderson et al. | Oct 2007 | A1 |
20070260245 | Malandain et al. | Nov 2007 | A1 |
20070265623 | Malandain et al. | Nov 2007 | A1 |
20070265624 | Zucherman et al. | Nov 2007 | A1 |
20070265625 | Zucherman et al. | Nov 2007 | A1 |
20070265626 | Seme | Nov 2007 | A1 |
20070270822 | Heinz | Nov 2007 | A1 |
20070270823 | Trieu et al. | Nov 2007 | A1 |
20070270824 | Lim et al. | Nov 2007 | A1 |
20070270826 | Trieu et al. | Nov 2007 | A1 |
20070270827 | Lim et al. | Nov 2007 | A1 |
20070270828 | Bruneau et al. | Nov 2007 | A1 |
20070270829 | Carls et al. | Nov 2007 | A1 |
20070270834 | Bruneau et al. | Nov 2007 | A1 |
20070272259 | Allard et al. | Nov 2007 | A1 |
20070276368 | Trieu et al. | Nov 2007 | A1 |
20070276369 | Allard et al. | Nov 2007 | A1 |
20070276370 | Altarac et al. | Nov 2007 | A1 |
20070276372 | Malandain et al. | Nov 2007 | A1 |
20070276373 | Malandain | Nov 2007 | A1 |
20070276493 | Malandain et al. | Nov 2007 | A1 |
20070276496 | Lange et al. | Nov 2007 | A1 |
20070276497 | Anderson | Nov 2007 | A1 |
20070276500 | Zucherman et al. | Nov 2007 | A1 |
20080015700 | Zucherman et al. | Jan 2008 | A1 |
20080021468 | Zucherman et al. | Jan 2008 | A1 |
20080021560 | Zucherman et al. | Jan 2008 | A1 |
20080021561 | Zucherman et al. | Jan 2008 | A1 |
20080027545 | Zucherman et al. | Jan 2008 | A1 |
20080027552 | Zucherman et al. | Jan 2008 | A1 |
20080027553 | Zucherman et al. | Jan 2008 | A1 |
20080033445 | Zucherman et al. | Feb 2008 | A1 |
20080033553 | Zucherman et al. | Feb 2008 | A1 |
20080033558 | Zucherman et al. | Feb 2008 | A1 |
20080033559 | Zucherman et al. | Feb 2008 | A1 |
20080039853 | Zucherman et al. | Feb 2008 | A1 |
20080039858 | Zucherman et al. | Feb 2008 | A1 |
20080039859 | Zucherman et al. | Feb 2008 | A1 |
20080039945 | Zucherman et al. | Feb 2008 | A1 |
20080039946 | Zucherman et al. | Feb 2008 | A1 |
20080039947 | Zucherman et al. | Feb 2008 | A1 |
20080045958 | Zucherman et al. | Feb 2008 | A1 |
20080045959 | Zucherman et al. | Feb 2008 | A1 |
20080046081 | Zucherman et al. | Feb 2008 | A1 |
20080046085 | Zucherman et al. | Feb 2008 | A1 |
20080046086 | Zucherman et al. | Feb 2008 | A1 |
20080046087 | Zucherman et al. | Feb 2008 | A1 |
20080046088 | Zucherman et al. | Feb 2008 | A1 |
20080051785 | Zucherman et al. | Feb 2008 | A1 |
20080051898 | Zucherman et al. | Feb 2008 | A1 |
20080051899 | Zucherman et al. | Feb 2008 | A1 |
20080051904 | Zucherman et al. | Feb 2008 | A1 |
20080051905 | Zucherman et al. | Feb 2008 | A1 |
20080058806 | Klyce et al. | Mar 2008 | A1 |
20080058807 | Klyce et al. | Mar 2008 | A1 |
20080058808 | Klyce et al. | Mar 2008 | A1 |
20080058941 | Zucherman et al. | Mar 2008 | A1 |
20080065086 | Zucherman et al. | Mar 2008 | A1 |
20080065212 | Zucherman et al. | Mar 2008 | A1 |
20080065213 | Zucherman et al. | Mar 2008 | A1 |
20080065214 | Zucherman et al. | Mar 2008 | A1 |
20080071378 | Zucherman et al. | Mar 2008 | A1 |
20080086212 | Zucherman et al. | Apr 2008 | A1 |
20080167655 | Wang et al. | Jul 2008 | A1 |
20080167656 | Zucherman et al. | Jul 2008 | A1 |
20080167657 | Greenhalgh | Jul 2008 | A1 |
20080172057 | Zucherman et al. | Jul 2008 | A1 |
20080177272 | Zucherman et al. | Jul 2008 | A1 |
20080183210 | Zucherman et al. | Jul 2008 | A1 |
20080188895 | Cragg et al. | Aug 2008 | A1 |
20080195152 | Altarac et al. | Aug 2008 | A1 |
20080208344 | Kilpela et al. | Aug 2008 | A1 |
20080215058 | Zucherman et al. | Sep 2008 | A1 |
20080221692 | Zucherman et al. | Sep 2008 | A1 |
20080228225 | Trautwein et al. | Sep 2008 | A1 |
20080234824 | Youssef et al. | Sep 2008 | A1 |
20080287997 | Altarac et al. | Nov 2008 | A1 |
20080288075 | Zucherman et al. | Nov 2008 | A1 |
20080294263 | Altarac et al. | Nov 2008 | A1 |
20080319550 | Altarac et al. | Dec 2008 | A1 |
20090118833 | Hudgins et al. | May 2009 | A1 |
20090125030 | Tebbe et al. | May 2009 | A1 |
20090138046 | Altarac et al. | May 2009 | A1 |
20090138055 | Altarac et al. | May 2009 | A1 |
20090222043 | Altarac et al. | Sep 2009 | A1 |
20090248079 | Kwak et al. | Oct 2009 | A1 |
20090292315 | Trieu | Nov 2009 | A1 |
20100042217 | Zucherman et al. | Feb 2010 | A1 |
20100082108 | Zucherman et al. | Apr 2010 | A1 |
20100262243 | Zucherman et al. | Oct 2010 | A1 |
20100305611 | Zucherman et al. | Dec 2010 | A1 |
20110313457 | Reglos et al. | Dec 2011 | A1 |
Number | Date | Country |
---|---|---|
69507480 | Sep 1999 | DE |
322334 | Jun 1989 | EP |
0767636 | Apr 1997 | EP |
0768843 | Apr 1997 | EP |
0959792 | Dec 1999 | EP |
1027004 | Aug 2000 | EP |
1030615 | Aug 2000 | EP |
1138268 | Oct 2001 | EP |
1330987 | Jul 2003 | EP |
1056408 | Dec 2003 | EP |
1343424 | Sep 2004 | EP |
1454589 | Sep 2004 | EP |
1148850 | Apr 2005 | EP |
1299042 | Mar 2006 | EP |
1578314 | May 2007 | EP |
1675535 | May 2007 | EP |
WO-2007121070 | Oct 2007 | IN |
WO-9404088 | Mar 1994 | WO |
WO-9426192 | Nov 1994 | WO |
WO-9525485 | Sep 1995 | WO |
WO-9531158 | Nov 1995 | WO |
WO-9600049 | Jan 1996 | WO |
WO-9829047 | Jul 1998 | WO |
WO-9921500 | May 1999 | WO |
WO-9921501 | May 1999 | WO |
WO-9942051 | Aug 1999 | WO |
WO-0013619 | Mar 2000 | WO |
WO-0044319 | Aug 2000 | WO |
WO-0044321 | Aug 2000 | WO |
WO-0128442 | Apr 2001 | WO |
WO-0191657 | Dec 2001 | WO |
WO-0191658 | Dec 2001 | WO |
WO-0203882 | Jan 2002 | WO |
WO-0207623 | Jan 2002 | WO |
WO-0207624 | Jan 2002 | WO |
WO 02051326 | Jul 2002 | WO |
WO-02067793 | Sep 2002 | WO |
WO-02071960 | Sep 2002 | WO |
WO-02076336 | Oct 2002 | WO |
WO-03007791 | Jan 2003 | WO |
WO-03007829 | Jan 2003 | WO |
WO-03008016 | Jan 2003 | WO |
WO-03015646 | Feb 2003 | WO |
WO-03024298 | Mar 2003 | WO |
WO-03045262 | Jun 2003 | WO |
03101350 | Dec 2003 | WO |
WO-03099147 | Dec 2003 | WO |
WO-03101350 | Dec 2003 | WO |
WO-2004073533 | Sep 2004 | WO |
WO-2004110300 | Dec 2004 | WO |
WO-2005009300 | Feb 2005 | WO |
WO-2005013839 | Feb 2005 | WO |
WO-2005025461 | Mar 2005 | WO |
WO-2005041799 | May 2005 | WO |
WO-2005044152 | May 2005 | WO |
WO-2005055868 | Jun 2005 | WO |
WO-2005079672 | Sep 2005 | WO |
WO-2005115261 | Dec 2005 | WO |
WO-2006033659 | Mar 2006 | WO |
WO-2006034423 | Mar 2006 | WO |
WO-2006039243 | Apr 2006 | WO |
WO-2006039260 | Apr 2006 | WO |
WO-2006063047 | Jun 2006 | WO |
WO-2006065774 | Jun 2006 | WO |
WO-2006102269 | Sep 2006 | WO |
WO-2006102428 | Sep 2006 | WO |
WO-2006102485 | Sep 2006 | WO |
WO-2006107539 | Oct 2006 | WO |
WO-2006110462 | Oct 2006 | WO |
WO-2006110464 | Oct 2006 | WO |
WO-2006110767 | Oct 2006 | WO |
WO-2006113080 | Oct 2006 | WO |
WO-2006113406 | Oct 2006 | WO |
WO-2006113814 | Oct 2006 | WO |
WO-2006118945 | Nov 2006 | WO |
WO-2006119235 | Nov 2006 | WO |
WO-2006119236 | Nov 2006 | WO |
WO-2006135511 | Dec 2006 | WO |
WO-2007015028 | Feb 2007 | WO |
WO-2007035120 | Mar 2007 | WO |
WO-2007075375 | Jul 2007 | WO |
WO-2007075788 | Jul 2007 | WO |
WO-2007075791 | Jul 2007 | WO |
WO-2007089605 | Aug 2007 | WO |
WO-2007089905 | Aug 2007 | WO |
WO-2007089975 | Aug 2007 | WO |
WO-2007097735 | Aug 2007 | WO |
WO-2007109402 | Sep 2007 | WO |
WO-2007110604 | Oct 2007 | WO |
WO-2007111795 | Oct 2007 | WO |
WO-2007111979 | Oct 2007 | WO |
WO-2007111999 | Oct 2007 | WO |
WO-2007117882 | Oct 2007 | WO |
WO-2007127550 | Nov 2007 | WO |
WO-2007127588 | Nov 2007 | WO |
WO-2007127677 | Nov 2007 | WO |
WO-2007127689 | Nov 2007 | WO |
WO-2007127694 | Nov 2007 | WO |
WO-2007127734 | Nov 2007 | WO |
WO-2007127736 | Nov 2007 | WO |
WO-2007131165 | Nov 2007 | WO |
WO-2007134113 | Nov 2007 | WO |
WO-2008048645 | Apr 2008 | WO |
WO-2006045094 | Apr 2006 | WS |
Entry |
---|
European Office Action Application No. EP05849654.8; Applicant: The Board of Trustees of the Leland Stanford Junior University; Date of Completion: Jun. 21, 2011, 4 pages. |
Non-Final Office Action; U.S. Appl. No. 12/205,511 Mailing Date: Apr. 20, 2011 9 pages. |
Non-Final Office Action; U.S. Appl. No. 12/358,010 Mailing Date: Jul. 14, 2011; 9 pages. |
Supplementary European Search Report; Application No. EP07861426.0; Applicant: Vertiflex, Inc; Date of Completion: Jun. 7 2011, 6 pages. |
Supplementary European Search Report; Application No. EP09702116.6; Applicant: Vertiflex, Inc; Date of Completion: Feb. 11, 2011, 6 pages. |
Supplementary European Search Report; Application No. EP11151901.3; Applicant: Vertiflex, Inc; Date of Completion: Apr. 7, 2011, 6 pages. |
Final Office Action; U.S. Appl. No. 11/006,502; Mailing Date: Aug. 17, 2009, 7 pages. |
Non-Final Office Action; U.S. Appl. No. 11/006,502; Mailing Date: Nov. 7, 2008, 7 pages. |
Final Office Action; U.S. Appl. No. 11/006,521; Mailing Date: May 17, 2010, 10 pages. |
Final Office Action; U.S. Appl. No. 11/006,521; Mailing Date: Dec. 5, 2008, 10 pages. |
Final Office Action; U.S. Appl. No. 11/052,002; Mailing Date: Apr. 1, 2009, 7 pages. |
Final Office Action; U.S. Appl. No. 11/079,006; Mailing Date: Nov. 10, 2009, 7 pages. |
Final Office Action; U.S. Appl. No. 11/190,496; Mailing Date: May 19. 2009, 8 pages. |
Final Office Action; U.S. Appl. No. 11/305,820; Mailing Date: Jun. 16, 2008, 9 pages. |
Final Office Action; U.S. Appl. No. 11/314,712; Mailing Date: Sep. 4, 2009, 9 pages. |
International Search Report and Written Opinion; Application No. PCT/US2005/038026; Mailing Date: Apr. 22, 2008, 9 pages. |
International Search Report and Written Opinion; Application No. PCT/US2005/044256; Mailing Date: Jul. 28, 2006, 7 pages. |
International Search Report and Written Opinion; Application No. PCT/US2006/047824; Mailing Date: Oct. 16, 2008, 3 pages. |
International Search Report and Written Opinion; Application No. PCT/US2006/048611; Mailing Date: Oct. 14, 2008; 10 pages. |
International Search Report and Written Opinion; Application No. PCT/US2006/048614; Mailing Date: Feb. 3, 2006; 23 pages. |
International Search Report and Written Opinion; Application No. PCT/US2007/022171; Mailing Date: Apr. 15, 2008, 13 pages. |
International Search Report and Written Opinion; Application No. PCT/US2007/023312; Mailing Date: May 22, 2008, 14 pages. |
International Search Report and Written Opinion; Application No. PCT/US2008/004901; Mailing Date: Aug. 19, 2008, 7 pages. |
International Search Report and Written Opinion; Application No. PCT/US2008/008382; Mailing Date: Mar. 2, 2009, 12 pages. |
International Search Report and Written Opinion; Application No. PCT/US2008/008983; Mailing Date: Feb. 23, 2009, 7 pages. |
International Search Report and Written Opinion; Application No. PCT/US2008/075487; Mailing Date: Dec. 31, 2008, 7 pages. |
International Search Report and Written Opinion; Application No. PCT/US2008/087527; Mailing Date: Jul. 30, 2009, 7 pages. |
International Search Report and Written Opinion; Application No. PCT/US2009/031150; Mailing Date: Aug. 28, 2009, 5 pages. |
Minns, R.J., et al., “Preliminary Design and Experimental Studies of a Noval Soft Implant for Correcting Sagittal Plane Instability in the Lumbar Spine,” (1997) Spine, 22(16): 1819-1827. |
Non-Final Office Action; U.S. Appl. No. 10/970,843; Mailing Date: Apr. 29, 2008, 9 pages. |
Non-Final Office Action; U.S. Appl. No. 10/970,843; Mailing Date: Oct. 8, 2009, 8 pages. |
Non-Final Office Action; U.S. Appl. No. 11/006,521; Mailing Date: Feb. 28, 2008, 13 pages. |
Non-Final Office Action; U.S. Appl. No. 11/006,521; Mailing Date: Aug. 26, 2009, 9 pages. |
Non-Final Office Action; U.S. Appl. No. 11/052,002; Mailing Date: Sep. 18, 2007, 7 pages. |
Non-Final Office Action; U.S. Appl. No. 11/052,002; Mailing Date: Dec. 24, 2009, 6 pages. |
Non-Final Office Action; U.S. Appl. No. 11/079,006; Mailing Date: Jan. 30, 2009, 7 pages. |
Non-Final Office Action; U.S. Appl. No. 11/079,006; Mailing Date: Sep. 18, 2007, 6 pages. |
Non-Final Office Action; U.S. Appl. No. 11/190,496; Mailing Date: Aug. 25, 2008, 6 pages. |
Non-Final Office Action; U.S. Appl. No. 11/190,496; Mailing Date: Oct. 31, 2007, 7 pages. |
Non-Final Office Action; U.S. Appl. No. 11/305,820; Mailing Date: Oct. 9, 2007, 8 pages. |
Non-Final Office Action; U.S. Appl. No. 11/314,712; Mailing Date: Jan. 21, 2009, 8 pages. |
Non-Final Office Action; U.S. Appl. No. 11/582,874; Mailing Date: Jan. 4, 2010, 9 pages. |
Non-Final Office Action; U.S. Appl. No. 11/593,995; Mailing Date: Apr. 19, 2010, 10 pages. |
Supplementary European Search Report; Application No. EP05849654.6; Applicant: Vertiflex, Inc; Date of Completion: May 15, 2009, 10 pages. |
Supplementary European Search Report; Application No. EP07861721.4; Applicant: Vertiflex, Inc; Date of Completion: Nov. 24, 2009, 6 pages. |
Supplementary European Search Report; Application No. EP09170304.1; Applicant: Vertiflex, Inc; Date of Completion: Nov. 11, 2009, 5 pages. |
Supplementary European Search Report; Application No. EP09170338.9; Applicant: Vertiflex, Inc; Date of Completion: Nov. 12, 2009, 6 pages. |
Swan, Colby, “Preliminary Design and Experimental Studies of a Novel Soft Implant for Correcting Sogittal P{lane Instability in the Lumbar Spine,” Spine, 1997, 22(16), 1826-1827. |
Final Office Action; U.S. Appl. No. 10/970,843; Mailing Date: Feb. 12, 2009, 7 pages. |
Final Office Action; U.S. Appl. No. 10/970,843; Mailing Date: Jul. 2, 2010, 9 pages. |
Final Office Action; U.S. Appl. No. 11/052,002; Mailing Date: Sep. 1, 2010, 7 pages. |
Final Office Action; U.S. Appl. No. 11/582,874; Mailing Date: Sep. 10, 2010, 10 pages. |
International Search Report and Written Opinion; Application No. PCT/US2009/036561; Mailing Date: Sep. 17, 2009, 12 pages. |
Non-Final Office Action; U.S. Appl. No. 12/338,793; Mailing Date: Sep. 21, 2010, 9 pages. |
Number | Date | Country | |
---|---|---|---|
20110106160 A1 | May 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11305820 | Dec 2005 | US |
Child | 12844365 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11190496 | Jul 2005 | US |
Child | 11305820 | US | |
Parent | 11079006 | Mar 2005 | US |
Child | 11190496 | US | |
Parent | 11052002 | Feb 2005 | US |
Child | 11079006 | US | |
Parent | 11006502 | Dec 2004 | US |
Child | 11052002 | US | |
Parent | 10970843 | Oct 2004 | US |
Child | 11006502 | US |